Clinical Trial Detail

NCT ID NCT01677559
Title Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

Advanced Solid Tumor

Therapies

Alisertib + Nab-paclitaxel

Age Groups: adult

No variant requirements are available.